2gfd: Difference between revisions
Jump to navigation
Jump to search
m Protected "2gfd" [edit=sysop:move=sysop] |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2gfd.png|left|200px]] | [[Image:2gfd.png|left|200px]] | ||
{{STRUCTURE_2gfd| PDB=2gfd | SCENE= }} | {{STRUCTURE_2gfd| PDB=2gfd | SCENE= }} | ||
===GRP94 in complex with the novel HSP90 Inhibitor Radamide=== | ===GRP94 in complex with the novel HSP90 Inhibitor Radamide=== | ||
{{ABSTRACT_PUBMED_19361515}} | {{ABSTRACT_PUBMED_19361515}} | ||
Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
*[[Endoplasmin]] | *[[Endoplasmin|Endoplasmin]] | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:019361515</ref><references group="xtra"/> | ||
[[Category: Canis lupus familiaris]] | [[Category: Canis lupus familiaris]] | ||
[[Category: Gewirth, D T.]] | [[Category: Gewirth, D T.]] |
Revision as of 10:46, 27 July 2012
GRP94 in complex with the novel HSP90 Inhibitor RadamideGRP94 in complex with the novel HSP90 Inhibitor Radamide
Template:ABSTRACT PUBMED 19361515
About this StructureAbout this Structure
2gfd is a 2 chain structure of Endoplasmin with sequence from Canis lupus familiaris. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Immormino RM, Metzger LE 4th, Reardon PN, Dollins DE, Blagg BS, Gewirth DT. Different poses for ligand and chaperone in inhibitor-bound Hsp90 and GRP94: implications for paralog-specific drug design. J Mol Biol. 2009 May 22;388(5):1033-42. Epub 2009 Apr 8. PMID:19361515 doi:10.1016/j.jmb.2009.03.071